Antiviral-HIV (Antiretroviral) Protease Inhibitors

Antiviral-HIV (antiretroviral) protease inhibitors constitute a therapeutic class of medications used primarily in combination antiretroviral therapy for the management and treatment of human immunodeficiency virus type 1 (HIV-1) infection

Antiviral-HIV (antiretroviral) protease inhibitors constitute a therapeutic class of medications used primarily in combination antiretroviral therapy for the management and treatment of human immunodeficiency virus type 1 (HIV-1) infection These agents function by binding selectively to the active site of the viral HIV protease enzyme, which prevents the essential cleavage of nascent Gag and Gag-Pol precursor polyproteins By disrupting this critical maturation step during viral replication, the ...

These agents function by binding selectively to the active site of the viral HIV protease enzyme, which prevents the essential cleavage of nascent Gag and Gag-Pol precursor polyproteins By disrupting this critical maturation step during viral replication, the drugs prevent the formation of mature, infectious virions, thereby lowering viral load and impeding progression to acquired immunodeficiency syndrome (AIDS)

By disrupting this critical maturation step during viral replication, the drugs prevent the formation of mature, infectious virions, thereby lowering viral load and impeding progression to acquired immunodeficiency syndrome (AIDS)